Zytiga - latest news (June 2, 2023)

AstraZeneca and MSD’s Lynparza combo bags FDA approval for prostate cancer

The US Food and Drug Administration (FDA) has granted a combination of AstraZeneca and MSD’s Lynparza (olaparib), with ...
www.pharmaceutical-technology.com | 10 hours ago
FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer

The FDA has approved the PARP inhibitor olaparib (Lynparza) in combination with abiraterone (Zytiga) for BRCA-mutated ...
www.medpagetoday.com | 9 hours ago
Lockerbie bomber survived 3 more years after getting cancer drug denied to NHS

Respected oncologist Professor Karol Sikora (inset) explains how a cancer drug initially denied to NHS patients, extended the ...
www.msn.com |
FDA ap­proves As­traZeneca's Lyn­parza com­bo for adults with BR­CA-mu­tat­ed prostate can­cer

In April, an FDA adcomm gave the thumbs up to AstraZeneca’s blockbuster PARP inhibitor Lynparza label expansion into prostate ...
endpts.com | 15 hours ago
As­traZeneca gives up on late-stage IL-23 drug due to tri­al de­lays, com­pet­i­tive land­scape

AstraZeneca is shelving an IL-23 antibody that’s been through a winding journey around pharma — including stops at Amgen and ...
endpts.com | 15 hours ago
FDA clears narrow use of Lynparza in early prostate cancer, continuing ‘shift’ on PARP drugs

The new approval covers earlier use, alongside one of those treatments — Zytiga — and a steroid. Still, treatment isn’t cleared for prostate cancer broadly, as the developers had originally hoped. The ...
www.biopharmadive.com | 10 hours ago
China’s 4+7 drug procurement policy and its impact on the pharma industry

Therefore, it is important to follow any changes to China’s pharma industry, since the impact could be global. Certainly, 4+7 ...
pharmaphorum.com | 13 days ago
Certain Toxic Effects Higher With Newer Prostate Cancer Therapies

Currently, there are four second-generation AAs approved by the FDA for metastatic hormone-sensitive prostate cancer: abiraterone (Zytiga), enzalutamide (Xtandi), apalutamide (Erleada), and ...
www.medpagetoday.com | 6 days ago
nE |
© 2022 Latest news Norway